Mike Sheen of Investment Week features Hardman & Co MiFID II Monitor data highlight drop in liquidity and research coverage.
It has been a busy year at Hardman & Co, we have welcomed new team members, new clients, and given our brand a makeover. 2018 has also been a landmark year for us, celebrating 21 years in business. The launch of our MiFID II Monitor We have launched the MiFIDII monitor, designed to track the […]
Titon named as one of the ten small-cap companies to make Simon Thompson’s 2018 Bargain Shares Portfolio.
‘Market Minnows: Cancer firm Advanced Oncotherapy might be a long-term winner’.
Something brand new from Hardman & Co.
Advisers need to look at the quality of governance behind business relief products.
Keith Hiscock says revenue from its sponsored segment has grown 50 percent in the first half from the previous year.
Dr Brian Moretta on the Adviser Hour by GrowthInvest, panel discussion on estate planning and IHT, including current government led overview of the market.
‘For smaller companies, the concern is that declining coverage also curbs trading volumes, making it harder for them to raise capital, transfer stakes or meet institutional investors’ liquidity requirements.’